The MELGEN European Training Network (ETN) will create a co-operative environment for research and training in melanoma research, with the ultimate aim of
improving precision medicine for patients with the disease.
Not exact matches
«Patients aren't the only ones whose lives will be
improved by
precision medicine,» writes Black.
Collins called the project a «cornerstone» of
precision medicine: «The goal here is to be the foundation for almost everything you want to know about future individualized care and
improved health.»
As the end products and biological effectors of gene expression, proteins are crucial for
improving our understanding of human biology, developing new and better drugs, and advancing
precision medicine.
Largest project yet to link medical records and detailed genetic data suggests
precision medicine could
improve patient care
This new knowledge is also making
precision medicine a reality by enabling the development of highly targeted therapies that offer the potential for
improved treatment outcomes, especially for patients battling cancer.
This new commitment to the
precision medicine initiative will provide additional opportunities over the next three years for physicians to analyze the genomic profiles of pediatric patients to better understand their cancers and help
improve treatment options.
They included efforts to prepare communities to adapt to climate change; the cancer moonshot,
precision medicine, and brain research in the health arena; a network of advanced manufacturing institutes to recapture global industrial dominance; and public - private partnerships to
improve science and math education.
«In time, these findings should help us assign patients to the appropriate clinical trial and to
improve the design of clinical trials — particularly for
precision medicines that target the newly identified genetic alterations,» said Brent Orr, MD, PhD, of St. Jude Pathology.
(SALT LAKE CITY)-- The potential to treat, cure or even prevent illness through
precision medicine has raised hope for
improving the health of people worldwide, but it also has generated complex scientific, legal, ethical and social questions that must be answered for that promise to become real.
LOS ANGELES, Calif. & BOSTON, Mass. — Scientists at Cedars - Sinai and Emulate, Inc. are pioneering a Patient - on - a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant — a new approach to
precision medicine for
improving patient care and health.
These pre-clinical results are encouraging and demonstrate a fascinating approach to bringing
improved patient outcomes that would enable rapid advances in
precision medicine and therapeutic stratification in the future.»
Targeted treatment up front
improves survival for advanced prostate cancer, and we predict a change in thinking for
precision cancer
medicine.
From our earliest research that established cancer as a genetic disease to today's work in
precision medicine, our unswerving focus on genetics and genomics continues to generate advances that
improve human health.
Researchers are hopeful that proteogenomics, the integrated study of proteomics and genomics, may
improve our ability to prevent, diagnose, and treat cancer at the molecular level using
precision medicine.